Belhaven Biopharma


Belhaven Biopharma is dedicated to developing innovative, accessible, and effective allergy treatments, with a focus on needle-free, dry powder nasal epinephrine solutions like Nasdepi®. Their mission is to make lifesaving allergy medications more accessible, easier to administer, and environmentally sustainable, aiming to improve emergency care worldwide.

Industries

Biotechnology
Clinical Trials
Pharmaceutical
Biotechnology Research

Nr. of Employees

small (1-50)

Belhaven Biopharma

Durham, North Carolina, United States


Patents

Intranasal composition of pharmaceutical countermeasures for chemical warfare nerve agents and accidental exposure to organophosphate pesticides

US-12102629-B1

View Details

Dry powder formulations of epinephrine and associated methods

US-12097287-B2

View Details

Medical counter measures including dry powder formulations and associated methods

US-12005185-B2

View Details

Dry powder formulations of epinephrine and associated methods

US-11872308-B2

View Details

Dry powder formulations of epinephrine and associated methods

US-11617716-B2

View Details

Intranasal composition of pharmaceutical countermeasures for chemical warfare nerve agents and accidental exposure to organophosphate pesticides

US-11433063-B1

View Details

Products

Dry powder epinephrine nasal spray (unit-dose nasal powder device)

A needle-free, unit-dose dry powder nasal delivery product under clinical development to provide intranasal epinephrine for treatment of severe allergic reactions and anaphylaxis; designed for rapid absorption, passive operation, heat stability, and extended shelf life.

Nasdepi®

A needle-free epinephrine option designed for simple, rapid intranasal use during severe allergic reactions and anaphylaxis.


Services

Early-phase clinical study design and execution combined with regulatory planning focused on bioequivalence pathways to accelerate approvals of reformulated drugs.

Development of spray-dried nasal powder formulations and passive unit-dose nasal delivery devices intended for emergency medication administration.

Comparative pharmacokinetic and bioavailability testing in animal models and analytical studies such as nasal deposition assessments and stability evaluations.

Expertise Areas

  • Dry powder nasal drug delivery
  • Formulation development and spray drying
  • Pharmacokinetics and bioavailability studies
  • Early-phase clinical trial management
  • Show More (6)

Key Technologies

  • Spray-dried powder formulation
  • Dry powder intranasal delivery
  • Intranasal nasal mucosa absorption
  • Pharmacokinetic (PK) and bioavailability testing
  • Show More (6)

News & Updates

Discussion on the environmental impact of traditional EpiPens and the sustainable benefits of Nasdepi®, a needle-free nasal spray alternative.

Practical tips for managing allergies and how Nasdepi® offers fast, needle-free relief in emergencies.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.